On May 22, Jen Steinmetz co-presented “Artificial Intelligence (AI): The Future is Now” at the 2024 DRI Drug and Medical Device Seminar in Washington, D.C. Jen and her co-presenters discussed the current landscape and pros and cons of AI used in business and litigation, explored how AI and machine learning are transforming both development and FDA regulation of medical devices, and shared strategies to guide clients through the new business challenges posed by these fast-paced changes.